https://crstodayeurope.com/news/fda-clears-complement-therapeutics-ind-application-for-ctx001-gene-therapy-in-ga/2484178/daily0.7https://crstodayeurope.com/news/johnson-johnson-marks-100000-us-implants-of-tecnis-odyssey-iol-and-showcases-innovations-at-aao-2025/2484177/daily0.7https://crstodayeurope.com/news/glaukos-to-highlight-innovations-at-the-2025-american-academy-of-ophthalmology-annual-meeting/2484175/daily0.7https://crstodayeurope.com/news/bvi-receives-fda-approval-for-finevision-hp-trifocal-iol/2484174/daily0.7https://crstodayeurope.com/news/core-highlights-emerging-focus-on-pre-myopia-in-latest-contact-lens-update/2484173/daily0.7https://crstodayeurope.com/news/rayner-secures-fda-approval-for-rayone-emv-toric-iol/2484172/daily0.7https://crstodayeurope.com/news/konan-medical-receives-ce-marking-for-objectivefield-analyzer-ofa/2484170/daily0.7https://crstodayeurope.com/news/tilak-receives-positive-opinion-for-early-reimbursement-of-odysight-telemonitoring-device/2484169/daily0.7https://crstodayeurope.com/news/oculus-smartfield-perimeter-launches-aboard-the-international-space-station-to-support-vision-research/2484168/daily0.7https://crstodayeurope.com/news/alcon-showcases-breakthrough-innovations-and-new-clinical-data-at-aao-2025/2484167/daily0.7https://crstodayeurope.com/news/lovell-government-services-and-defeye-partner-to-expand-access-to-biovance-ocular-biologics-across-federal-healthcare-systems/2484164/daily0.7https://crstodayeurope.com/news/bloomberg-philanthropies-launches-75-million-vision-initiative-to-expand-global-access-to-eye-care/2484163/daily0.7https://crstodayeurope.com/news/nurexone-demonstrates-reproducible-dose-dependent-vision-recovery-in-preclinical-glaucoma-model/2484162/daily0.7https://crstodayeurope.com/news/zeiss-to-showcase-advancements-in-ophthalmic-visualization-and-digital-workflow-at-aao-2025/2484161/daily0.7https://crstodayeurope.com/news/horizon-surgical-systems-announces-worlds-first-robotic-cataract-surgery-using-the-polaris-platform/2484160/daily0.7https://crstodayeurope.com/news/biotech-healthcare-unveils-optiflex-xtense-comfort-plus-edof-iol/2484159/daily0.7https://crstodayeurope.com/news/eyedura-therapeutics-partners-with-seri-to-advance-insulin-based-topical-therapy-for-neurotrophic-keratitis/2484157/daily0.7https://crstodayeurope.com/news/sightglass-vision-new-18-month-data-reinforce-dot-lens-effectiveness/2484152/daily0.7https://crstodayeurope.com/news/oculis-advances-privosegtor-into-registrational-program-for-neuro-ophthalmology-after-positive-fda-meeting/2486118/daily0.7https://crstodayeurope.com/news/virtual-field-launches-dicom-360-sync-connectivity-hub/2484151/daily0.7https://crstodayeurope.com/news/kala-halts-development-of-investigational-pced-eye-drop-after-phase-2b-trial-fails-to-meet-endpoints/2484150/daily0.7https://crstodayeurope.com/news/cirrus-therapeutics-raises-11-million-to-advance-first-in-class-ocular-gene-therapy-targeting-dry-amd/2484149/daily0.7https://crstodayeurope.com/news/nicoxs-ncx-470-demonstrates-sustained-efficacy-through-12-months-in-phase-3-trial/2483845/daily0.7https://crstodayeurope.com/news/biotissue-announces-formation-of-medical-advisory-board-to-advance-regenerative-ocular-therapies/2483844/daily0.7https://crstodayeurope.com/news/op-ed-congress-must-not-dismantle-americas-vision-research-crown-jewel/2483843/daily0.7https://crstodayeurope.com/news/eyeq-technologies-rebrands-as-iqity-will-host-live-demonstrations-at-aao/2483842/daily0.7https://crstodayeurope.com/news/systematic-review-highlights-advances-in-topical-pharmacologic-treatments-for-dry-eye-disease/2483841/daily0.7https://crstodayeurope.com/news/defeye-inc-launches-as-independent-ophthalmic-biologics-company/2483840/daily0.7https://crstodayeurope.com/news/zeiss-vision-care-acquires-stake-in-tele-ophthalmology-platform-ocumeda/2483839/daily0.7https://crstodayeurope.com/news/opus-genetics-reports-positive-pediatric-data-from-opgx-lca5-phase-12-trial-in-leber-congenital-amaurosis-type-5/2483838/daily0.7https://crstodayeurope.com/news/lenz-therapeutics-announces-commercial-product-availability-of-vizz-in-the-united-states/2483837/daily0.7https://crstodayeurope.com/news/aurion-biotech-expands-leadership-team-promotes-andrew-torres-phd-to-chief-manufacturing-officer-and-sterling-chung-to-chief-regulatory-quality-officer-officer/2483836/daily0.7https://crstodayeurope.com/news/study-myopia-epidemic-in-china-doubles-in-one-generation/2483835/daily0.7https://crstodayeurope.com/news/lumibird-medical-introduces-absolu-icl-guru-integration-for-next-level-icl-sizing/2483834/daily0.7https://crstodayeurope.com/news/harrow-to-acquire-melt-pharmaceuticals/2483833/daily0.7https://crstodayeurope.com/news/harrow-expands-patient-first-access-with-launch-of-harrow-access-for-all/2483832/daily0.7https://crstodayeurope.com/news/researchers-combine-physics-ai-to-clarify-medical-images-for-eye-disease-diagnosis/2483831/daily0.7https://crstodayeurope.com/news/cleaner-air-may-protect-childrens-eyesight-international-study-finds/2483830/daily0.7https://crstodayeurope.com/news/amneal-pharmaceuticals-gains-fda-approval-for-generic-bimatoprost-ophthalmic-solution-001/2483829/daily0.7https://crstodayeurope.com/news/horizon-surgical-systems-appoints-rajesh-k-rajpal-md-as-chief-strategy-and-medical-officer/2483828/daily0.7https://crstodayeurope.com/news/atsena-therapeutics-completes-adult-dosing-in-lighthouse-gene-therapy-trial-for-x-linked-retinoschisis/2483827/daily0.7https://crstodayeurope.com/news/chicago-lighthouse-and-hadley-launch-video-initiative-to-support-older-adults-with-vision-loss/2483826/daily0.7https://crstodayeurope.com/news/idebenone-accepted-by-fda-for-priority-review-for-leber-hereditary-optic-neuropathy-lhon/2483825/daily0.7https://crstodayeurope.com/news/cornell-eye-on-a-chip-study-illuminates-pathway-behind-steroid-induced-glaucoma/2483824/daily0.7https://crstodayeurope.com/news/myopia-profile-unveils-ask-kate-an-ai-powered-assistant-for-childhood-myopia-management/2483823/daily0.7https://crstodayeurope.com/news/escrs-twice-daily-eye-drops-offer-non-surgical-option-for-presbyopia-2-year-study-shows/2483822/daily0.7https://crstodayeurope.com/news/major-device-launches-and-breakthroughs-spotlighted-at-escrs-2025-in-copenhagen/2483821/daily0.7https://crstodayeurope.com/news/iveena-delivery-systems-secures-2-million-nei-grant-to-advance-pediatric-myopia-therapy/2483820/daily0.7https://crstodayeurope.com/news/topcon-healthcare-unveils-tera-dry-eye-imager-for-dry-eye-diagnosis-and-management/2483819/daily0.7https://crstodayeurope.com/news/university-of-houston-and-ohio-state-to-lead-25m-national-trial-testing-atropine-to-prevent-myopia-onset/2483818/daily0.7https://crstodayeurope.com/news/jim-mcgrann-named-2026-prevent-blindness-person-of-vision/2483817/daily0.7https://crstodayeurope.com/news/optos-and-toku-partner-to-bring-ai-powered-bioage-to-us-eye-care-practices/2483816/daily0.7https://crstodayeurope.com/news/vyome-showcases-preclinical-data-for-first-topical-mycophenolate-eye-drop-to-treat-uveitis/2483815/daily0.7https://crstodayeurope.com/news/alcon-presents-new-data-showing-or-efficiency-with-unity-vitreoretinal-cataract-system/2483814/daily0.7https://crstodayeurope.com/news/the-eye-drink-launches-as-a-clinically-backed-ready-to-drink-vision-health-nutraceutical/2483813/daily0.7https://crstodayeurope.com/news/jj-presents-new-real-world-data-for-tecnis-puresee-iol-at-escrs/2483812/daily0.7https://crstodayeurope.com/news/eyexora-debuts-to-accelerate-global-ophthalmology-innovation-with-hub-and-spoke-model/2483811/daily0.7https://crstodayeurope.com/news/trial-examines-equivalence-of-hydrophilic-and-hydrophobic-iols-in-pco-prevention/2483810/daily0.7https://crstodayeurope.com/news/eyecool-therapeutics-appoints-vance-thompson-md-to-its-board-of-directors/2483809/daily0.7https://crstodayeurope.com/news/ziemer-presents-several-new-innovations-at-escrs-2025/2483808/daily0.7https://crstodayeurope.com/news/haag-streit-unveils-elara-900-slit-lamp-and-refractor-900-digital-phoropter/2483807/daily0.7https://crstodayeurope.com/news/fda-clears-moria-surgicals-xtra4-corneal-storage-solution/2483806/daily0.7https://crstodayeurope.com/news/university-of-houston-researchers-awarded-36m-to-investigate-vision-critical-gene/2483805/daily0.7https://crstodayeurope.com/news/sandoz-and-regeneron-reach-agreement-on-aflibercept-biosimilar-patent-disputes/2483804/daily0.7https://crstodayeurope.com/news/oculus-unveils-cornea-segmentation-display-for-pentacam-cornea-oct/2483803/daily0.7https://crstodayeurope.com/news/alcon-launches-first-fully-personalized-lasik-treatment-wavelight-plus-in-the-us-and-canada/2483802/daily0.7https://crstodayeurope.com/news/study-xiidra-significantly-reduces-end-of-day-dryness-and-discomfort-in-contact-lens-wearers/2483801/daily0.7https://crstodayeurope.com/news/topcon-healthcare-invests-in-senseye-to-advance-mental-health-diagnostics-through-the-eye/2483800/daily0.7https://crstodayeurope.com/news/alcon-highlights-new-innovations-and-study-findings-at-escrs/2483799/daily0.7https://crstodayeurope.com/news/centre-for-sight-highlights-review-confirming-superior-stability-of-double-c-loop-iol-design/2483798/daily0.7https://crstodayeurope.com/news/johnson-johnson-to-spotlight-tecnis-iol-data-and-innovations-at-escrs-2025/2483797/daily0.7https://crstodayeurope.com/news/heidelberg-engineering-makes-two-senior-appointments-to-leadership-team/2483796/daily0.7https://crstodayeurope.com/news/oculis-and-euretina-announce-2025-ramin-tadayoni-award-winner/2483795/daily0.7https://crstodayeurope.com/news/opus-genetics-doses-first-patient-in-pivotal-phase-3-trial-for-night-driving-impairment-after-refractive-surgery/2483794/daily0.7https://crstodayeurope.com/news/opzira-launches-with-goal-of-advancing-ocular-disease-detection-and-monitoring/2483793/daily0.7https://crstodayeurope.com/news/oertli-unveils-os-4-up-surgical-platform-at-euretina-and-escrs/2483792/daily0.7https://crstodayeurope.com/news/virtualens-launches-immersive-iol-simulator-to-transform-cataract-surgery-consultations/2483791/daily0.7https://crstodayeurope.com/news/alcon-completes-acquisition-of-lumithera/2483790/daily0.7https://crstodayeurope.com/news/bvi-unveils-virtuoso-next-generation-dual-function-phaco-vitrectomy-platform-in-europe/2483789/daily0.7https://crstodayeurope.com/news/new-world-medical-launches-ahmed-clearpath-st-expanding-options-for-glaucoma-surgery/2483788/daily0.7https://crstodayeurope.com/news/zeiss-to-showcase-expansion-of-ophthalmic-care-options-new-refractive-and-cataract-milestones-at-escrs/2483787/daily0.7https://crstodayeurope.com/news/iantrek-expands-clinical-evidence-for-alloflo-uveo-with-two-new-peer-reviewed-publications/2483786/daily0.7https://crstodayeurope.com/news/bausch-lomb-announces-new-scientific-data-and-educational-events-at-escrs/2483785/daily0.7https://crstodayeurope.com/news/haag-streit-appoints-thomas-lenzen-as-new-ceo/2483784/daily0.7https://crstodayeurope.com/news/heidelberg-and-orbis-expand-global-partnership-to-advance-eye-care-education-and-clinical-research/2483783/daily0.7https://crstodayeurope.com/news/glp-1-receptor-agonists-linked-to-reduced-uveitis-risk/2483782/daily0.7https://crstodayeurope.com/news/fda-once-again-turns-down-outlook-therapeutics-wet-amd-candidate/2483781/daily0.7https://crstodayeurope.com/news/plexitome-anterior-stromal-puncture-now-available-through-veo-ophthalmics/2483780/daily0.7https://crstodayeurope.com/news/altris-ai-launches-advanced-flagging-system-to-transform-oct-data-search/2483779/daily0.7https://crstodayeurope.com/news/ciliatech-secures-ce-certification-for-intercil-uveal-spacer/2483778/daily0.7https://crstodayeurope.com/news/zeiss-showcases-workflow-for-full-spectrum-of-retina-care-at-euretina/2483777/daily0.7https://crstodayeurope.com/news/boehringer-ingelheim-and-palatin-technologies-partner-to-develop-potential-melanocortin-receptor-for-retinal-diseases/2483776/daily0.7https://crstodayeurope.com/news/qlaris-bio-doses-first-patient-in-phase-ii-nightingale-trial-for-normal-tension-glaucoma/2483775/daily0.7https://crstodayeurope.com/news/fda-to-begin-publishing-adverse-event-data-daily/2483774/daily0.7https://crstodayeurope.com/news/ocumetics-announces-first-in-human-implantation-of-accommodating-iol/2483773/daily0.7https://crstodayeurope.com/news/vision-expo-west-announces-2025-program-and-new-features/2483772/daily0.7https://crstodayeurope.com/news/glaucoma-research-foundation-launches-treatment-accelerator-with-5-million-gift/2483771/daily0.7https://crstodayeurope.com/news/fda-grants-rmat-designation-to-veongens-vg801-for-stargardt-disease/2483770/daily0.7https://crstodayeurope.com/news/zeiss-receives-ce-mark-for-cirrus-pathfinder-ai-tool-with-automated-oct-assessment/2483769/daily0.7https://crstodayeurope.com/news/dr-pettey-named-ceo-of-moran-eye-center-and-department-chair-at-university-of-utah/2483768/daily0.7https://crstodayeurope.com/news/johnson-johnson-appoints-caroline-blackie-vice-president-of-medical-affairs-vision/2483767/daily0.7https://crstodayeurope.com/news/prevent-blindness-forms-new-diabetes-the-eyes-advisory-committee/2482934/daily0.7https://crstodayeurope.com/news/myra-vision-secures-fda-approval-to-initiate-us-based-ide-study-in-glaucoma/2482933/daily0.7https://crstodayeurope.com/news/vsy-biotechnology-launches-enova-hydrophobic-iols-with-rotaryjet-technology/2482932/daily0.7https://crstodayeurope.com/news/beyeonics-vision-secures-us-patent-for-ophthalmic-surgical-visualization-technology/2482931/daily0.7https://crstodayeurope.com/news/new-research-highlights-lumenis-dynamic-muscle-stimulation-technology-in-managing-lower-lid-laxity-and-blinking-quality/2482929/daily0.7https://crstodayeurope.com/news/nordic-pharmas-lacrifill-canalicular-gel-highlighted-in-landmark-dews-iii-report/2482927/daily0.7https://crstodayeurope.com/news/okyo-pharma-secures-funding-to-advance-urcosimod-for-neuropathic-corneal-pain/2482926/daily0.7https://crstodayeurope.com/news/polyactiva-enrolls-first-patient-in-us-phase-2b-clinical-trial-of-its-ocular-micro-implant-for-glaucoma-and-ocular-hypertension/2482925/daily0.7https://crstodayeurope.com/news/sight-sciences-publishes-24-month-sahara-rct-results-evaluating-tearcare-in-dry-eye-disease/2482923/daily0.7https://crstodayeurope.com/news/new-study-links-physical-activity-to-slower-glaucoma-progression/2482921/daily0.7https://crstodayeurope.com/news/mark-maire-appointed-ceo-of-rebion/2482920/daily0.7https://crstodayeurope.com/news/market-scope-investor-interest-in-ophthalmology-remains-strong/2482919/daily0.7https://crstodayeurope.com/news/kowa-initiates-phase-3-safety-trial-for-glaucoma-drug-candidate-ncx-470-in-japan/2482918/daily0.7https://crstodayeurope.com/news/alcon-to-acquire-staar-surgical-for-15-billion/2482917/daily0.7https://crstodayeurope.com/news/reciprocal-tariffs-take-effect-august-7-what-eye-care-professionals-need-to-know/2482916/daily0.7https://crstodayeurope.com/news/vision-advocates-rally-to-defend-national-eye-institute-from-funding-cuts-and-consolidation-threats/2482913/daily0.7https://crstodayeurope.com/news/lenz-therapeutics-receives-fda-approval-of-vizz-for-the-treatment-of-presbyopia/2482912/daily0.7https://crstodayeurope.com/news/bascom-palmer-eye-institute-tops-us-news-world-report-rankings-for-24th-year-in-a-row/2482911/daily0.7https://crstodayeurope.com/news/viridian-therapeutics-enters-collaboration-to-develop-and-commercialize-thyroid-eye-disease-therapies-in-japan/2482910/daily0.7https://crstodayeurope.com/news/stanton-optical-launches-advanced-eye-health-services-across-35-us-locations/2483766/daily0.7https://crstodayeurope.com/news/topcon-healthcare-acquires-intelligent-retinal-imaging-systems-to-enhance-connected-care-across-primary-and-eye-care/2482909/daily0.7https://crstodayeurope.com/news/alcon-announces-us-launch-of-tryptyr-for-dry-eye-disease/2482908/daily0.7https://crstodayeurope.com/news/boehringer-ingelheim-and-re-vana-therapeutics-announce-collaboration-to-develop-long-acting-ophthalmic-therapies/2482905/daily0.7https://crstodayeurope.com/news/ziemer-usa-announces-new-innovations-for-the-galilei-diagnostic-platform-and-femto-ldv-z8-femtosecond-laser-platform/2482904/daily0.7https://crstodayeurope.com/news/heidelberg-publishes-eye2gene-study-evaluating-potential-of-ai-powered-analysis/2482900/daily0.7https://crstodayeurope.com/news/the-vision-council-releases-updated-version-of-data-communication-standard/2482899/daily0.7https://crstodayeurope.com/news/orbis-flying-eye-hospital-begins-two-week-training-project-to-improve-eye-care-across-rwanda/2482898/daily0.7https://crstodayeurope.com/news/julia-haller-md-named-ceo-of-wills-eye-hospital/2482897/daily0.7https://crstodayeurope.com/news/cloudbreak-pharma-announces-positive-phase-2-results-for-cbt-004-in-patients-with-vascularized-pinguecula/2482896/daily0.7https://crstodayeurope.com/news/essilorluxottica-to-acquire-ophthalmic-lens-materials-division-of-pucore/2482895/daily0.7https://crstodayeurope.com/news/topcon-partners-with-okko-health-to-advance-home-based-vision-monitoring-and-patient-engagement/2482894/daily0.7https://crstodayeurope.com/news/viatris-fails-phase-3-study-of-mr-139-for-blepharitis/2482893/daily0.7https://crstodayeurope.com/news/clearside-biomedical-announces-plan-to-explore-strategic-alternatives-to-advance-its-proprietary-suprachoroidal-space-delivery-platform/2482892/daily0.7https://crstodayeurope.com/news/fda-accepts-reproxalap-application-for-dry-eye-disease/2483765/daily0.7https://crstodayeurope.com/news/polyactiva-announces-executive-team-appointments/2483764/daily0.7https://crstodayeurope.com/news/altris-ai-launches-altris-sync-app-allowing-ai-to-directly-sync-to-oct-devices-ai-now-connects-to-oct-devices-from-8-manufacturers-and-enables-analysis-of-historical-data/2482891/daily0.7https://crstodayeurope.com/news/harrow-enters-into-commercialization-agreement-with-samsung-bioepis-for-ophthalmology-biosimilars-portfolio-in-the-us/2482890/daily0.7https://crstodayeurope.com/news/nicox-and-kowa-sign-agreement-for-exclusive-rights-to-glaucoma-treatment-ncx-470-in-us-and-all-unlicensed-territories/2482889/daily0.7https://crstodayeurope.com/news/stuart-therapeutics-publishes-new-study-demonstrating-potential-of-collagen-mimetic-peptides-in-treating-ophthalmic-disease/2482887/daily0.7https://crstodayeurope.com/news/eyeduras-sustained-release-eye-drop-technology-wins-industry-honors/2482886/daily0.7https://crstodayeurope.com/news/krystal-biotech-announces-first-patient-dosed-in-phase-12-trial-of-kb801-for-the-treatment-of-neurotrophic-keratitis/2482883/daily0.7https://crstodayeurope.com/news/alcons-receives-health-canada-approval-for-unity-vcs/2482882/daily0.7https://crstodayeurope.com/news/wayne-caulder-joins-bausch-lomb-as-vice-president-and-general-manager-surgical-us/2482881/daily0.7https://crstodayeurope.com/news/the-vision-council-comments-on-impact-of-proposed-tariffs-on-optical-industry/2482880/daily0.7https://crstodayeurope.com/news/johnson-johnson-appoints-kelly-heaps-vice-president-of-us-sales-vision-care/2482879/daily0.7https://crstodayeurope.com/news/bluerock-therapeutics-announces-first-patient-treated-in-phase-12a-trial-of-opct-001-for-primary-photoreceptor-diseases/2482877/daily0.7https://crstodayeurope.com/news/vialase-announces-strategic-leadership-transitions/2482876/daily0.7https://crstodayeurope.com/news/alcon-to-acquire-lumithera-maker-of-photobiomodulation-device-for-the-treatment-of-dry-amd/2482873/daily0.7https://crstodayeurope.com/news/bausch-lomb-launches-dry-eye-education-campaign/2482872/daily0.7https://crstodayeurope.com/news/eyenovia-announces-rebranding-and-corporate-name-change-to-hyperion-defi-inc/2482871/daily0.7https://crstodayeurope.com/news/glaukos-announces-european-union-mdr-certification-for-istent-infinite-and-istent-inject-w/2482868/daily0.7https://crstodayeurope.com/news/ocumetics-initiates-first-in-human-study-of-accommodating-intraocular-lens/2482866/daily0.7https://crstodayeurope.com/news/nicox-announces-last-patient-completes-the-ncx-470-denali-phase-3-clinical-trial/2482865/daily0.7https://crstodayeurope.com/news/opus-genetics-announces-vega-3-phase-3-trial-met-primary-endpoint-for-phentolamine-ophthalmic-solution-075-for-the-treatment-of-presbyopia/2482863/daily0.7https://crstodayeurope.com/news/july-is-dry-eye-month-at-prevent-blindness-with-the-goal-to-raise-awareness-and-educate-the-public-on-the-eye-condition-1/2483763/daily0.7https://crstodayeurope.com/news/forsight-robotics-secures-125-million-in-series-b-funding-addressing-global-surgeon-shortage-and-demand-for-ophthalmic-surgery/2482862/daily0.7https://crstodayeurope.com/news/valorum-biologics-becomes-commercialization-partner-for-formycons-eylea-biosimilar-fyb203ahzantive-aflibercept-mrbb-in-the-united-states-and-canada/2482861/daily0.7https://crstodayeurope.com/news/stuart-therapeutics-announces-initial-results-of-phase-iii-clinical-trial-for-st-100-vezocolmitide-ophthalmic-solution-a-novel-dry-eye-disease-candidate/2483762/daily0.7https://crstodayeurope.com/news/hadley-and-notal-vision-partner-to-empower-patients-with-vision-loss-through-education-and-leading-technology/2482860/daily0.7https://crstodayeurope.com/news/qlaris-bio-to-present-new-clinical-and-preclinical-data-on-qls-111-at-2025-world-glaucoma-congress/2482859/daily0.7https://crstodayeurope.com/news/alcon-introduces-clareon-panoptix-pro-in-canada/2482857/daily0.7https://crstodayeurope.com/news/france-first-in-eu-to-reimburse-hoya-miyosmart-lens-for-childhood-myopia/2482856/daily0.7https://crstodayeurope.com/news/hadley-launches-donahoe-center-to-expand-emotional-support-for-vision-loss/2483761/daily0.7https://crstodayeurope.com/news/new-york-eye-and-ear-infirmary-of-mount-sinai-opens-first-comprehensive-center-for-refractive-solutions-in-new-york/2482855/daily0.7https://crstodayeurope.com/news/polyactiva-appoints-jerry-st-peter-as-ceo-secures-financing-to-advance-prezia-technology-platform/2482854/daily0.7https://crstodayeurope.com/news/johnson-johnson-launches-tecnis-odyssey-iol-in-europe-the-middle-east-and-canada/2482853/daily0.7https://crstodayeurope.com/news/amaros-expands-advisory-board-closes-series-a-financing/2482852/daily0.7https://crstodayeurope.com/news/aldeyra-resubmits-reproxalap-nda-for-the-treatment-of-dry-eye-disease/2482851/daily0.7https://crstodayeurope.com/news/sightview-appoints-tycene-fritcher-as-ceo/2482850/daily0.7https://crstodayeurope.com/news/tfos-dews-iii-report-published-for-updated-guidelines-for-diagnosis-and-management-of-ded/2482849/daily0.7https://crstodayeurope.com/news/heidelberg-engineering-launches-zinserlab-innovation-hub-to-accelerate-imaging-innovation-in-eye-care/2482848/daily0.7https://crstodayeurope.com/news/amneal-receives-fda-approval-for-prednisolone-acetate-ophthalmic-suspension/2482847/daily0.7https://crstodayeurope.com/news/qlaris-bio-developing-fixed-dose-combination-therapy-for-the-treatment-of-glaucoma/2482844/daily0.7https://crstodayeurope.com/news/ema-review-finds-rare-risk-of-vision-loss-associated-with-semaglutide-medicines/2482842/daily0.7https://crstodayeurope.com/news/harrow-acquires-us-commercial-rights-to-byqlovi-for-postoperative-inflammation-and-pain/2482841/daily0.7https://crstodayeurope.com/news/zeiss-clarus-700-receives-nmpa-approval-in-china/2482840/daily0.7https://crstodayeurope.com/news/sydnexis-announces-european-commission-approval-of-ryjunea-first-treatment-for-slowing-the-progression-of-pediatric-myopia/2482839/daily0.7https://crstodayeurope.com/news/eyecare4kids-names-maggie-cline-as-new-ceo/2482838/daily0.7https://crstodayeurope.com/news/nih-researchers-identify-brain-circuits-responsible-for-visual-acuity/2482836/daily0.7https://crstodayeurope.com/news/navigate-patient-solutions-adds-ophthalmology-leaders-to-its-medical-advisory-board/2482835/daily0.7https://crstodayeurope.com/news/bausch-lomb-launches-blink-nourish-and-blink-boost-lubricating-eye-drops-in-the-us/2482834/daily0.7https://crstodayeurope.com/news/haag-streit-launches-cornea-map-toric-assessment-feature-for-the-lenstar/2482833/daily0.7https://crstodayeurope.com/news/fda-accepts-tenpoints-new-drug-application-for-brimochol-pf-for-the-treatment-of-presbyopia/2482832/daily0.7https://crstodayeurope.com/news/iveena-submits-ind-application-to-the-fda-for-phase-2-clinical-trial-for-pediatric-myopia/2482830/daily0.7https://crstodayeurope.com/news/spyglass-pharma-raises-75-million-series-d-funding-to-advance-its-long-term-drug-delivery-platform-for-glaucoma-patients/2482829/daily0.7https://crstodayeurope.com/news/opus-genetics-phase-3-trial-for-phentolamine-ophthalmic-solution-meets-primary-endpoint-for-night-vision/2482828/daily0.7https://crstodayeurope.com/news/study-long-approved-hiv-drug-may-improve-vision-in-patients-diabetic-macular-edema-patients/2482826/daily0.7https://crstodayeurope.com/news/essilorluxottica-to-acquire-ophthalmology-network-optegra-clinics/2482825/daily0.7https://crstodayeurope.com/news/university-of-oklahoma-study-identifies-20-novel-variants-for-inherited-retinal-diseases/2482824/daily0.7https://crstodayeurope.com/news/alcon-receives-fda-approval-of-tryptyr-for-the-treatment-of-the-signs-and-symptoms-of-dry-eye-disease/2482823/daily0.7https://crstodayeurope.com/news/pangaea-data-secures-investment-from-topcon-healthcare-to-scale-ai-platform/2482821/daily0.7https://crstodayeurope.com/news/nicox-to-receive-milestone-payments-from-kowa-as-ncx-470-prepares-to-enter-phase-3-clinical-trials-in-japan/2482819/daily0.7https://crstodayeurope.com/news/nasa-astronauts-to-headline-heidelberg-engineerings-2025-international-spectralis-symposium/2482818/daily0.7https://crstodayeurope.com/news/bausch-lomb-launches-lumify-preservative-free-redness-reliever-eye-drops-in-the-united-states/2482814/daily0.7https://crstodayeurope.com/news/allotex-files-ide-with-fda-for-collagen-based-corneal-implant/2482813/daily0.7https://crstodayeurope.com/news/grifols-receives-fda-clearance-of-ind-application-for-phase-2-trial-of-immunoglobulin-drops-for-dry-eye-disease/2482812/daily0.7https://crstodayeurope.com/news/fda-grants-atia-vision-approval-to-begin-us-clinical-trial-of-omnivu-lens-system-in-patients-with-cataracts/2482811/daily0.7https://crstodayeurope.com/news/hoya-presents-new-clinical-evidence-on-myopia-management-and-launch-of-visureal-moveai-kids-module/2482810/daily0.7https://crstodayeurope.com/news/nationwide-recall-issued-for-multiple-otc-eye-care-products/2482809/daily0.7https://crstodayeurope.com/news/eye-go-secures-strategic-investment-from-topcon-healthcare/2482807/daily0.7https://crstodayeurope.com/news/sciencebased-health-expands-its-ophthalmology-clinical-advisory-panel/2482806/daily0.7https://crstodayeurope.com/news/intalight-receives-ce-mark-for-its-dream-oct-platform-approal-for-commercialization-in-europe/2482804/daily0.7https://crstodayeurope.com/news/new-world-medical-introduces-next-generation-streamline-surgical-system-1/2482803/daily0.7https://crstodayeurope.com/news/bausch-lomb-launches-zenlens-chroma-hoa-in-the-us/2482802/daily0.7https://crstodayeurope.com/news/the-alliance-for-healthcare-from-the-eye-launches-to-transform-disease-detection/2482801/daily0.7https://crstodayeurope.com/news/hoya-vision-care-presents-new-data-on-myopia-management-spectacle-lenses-at-arvo/2482800/daily0.7https://crstodayeurope.com/news/eyecool-therapeutics-announces-positive-results-from-pilot-study-in-patients-with-chronic-ocular-surface-pain-cosp/2482799/daily0.7https://crstodayeurope.com/news/perfuse-therapeutics-announces-positive-results-from-phase-12a-trial-of-per-001-intravitreal-implant-in-patients-with-glaucoma/2482794/daily0.7https://crstodayeurope.com/news/topcon-healthcare-launches-idhea-to-fuel-ai-and-digital-health-innovation-from-the-eye/2482792/daily0.7https://crstodayeurope.com/news/registration-now-open-for-neuro-optometric-rehabilitation-association-nora-2025-conference/2482791/daily0.7https://crstodayeurope.com/news/bausch-lomb-receives-ce-mark-approval-for-preloaded-luxlife-full-range-of-vision-iols/2482789/daily0.7https://crstodayeurope.com/news/aldeyra-plans-to-resubmit-nda-for-ded-candidate-reproxilap-after-dry-eye-chamber-trial-results/2482788/daily0.7https://crstodayeurope.com/news/moorfields-eye-hospital-ucl-institute-of-ophthalmology-and-topcon-partner-to-launch-new-medical-technology-company/2482786/daily0.7https://crstodayeurope.com/news/iantrek-hits-2000-procedures-for-new-bio-interventional-technology-alloflo-uveo/2482785/daily0.7https://crstodayeurope.com/news/johnson-johnson-to-present-new-scientific-data-on-acuvue-oasys-max-1-day-tecnis-odyssey-and-a-purely-refractive-next-generation-edf-iol-at-arvo/2482783/daily0.7https://crstodayeurope.com/news/sydnexis-announces-three-abstracts-accepted-for-poster-presentations-at-arvo/2482780/daily0.7https://crstodayeurope.com/news/alcon-offers-eye-care-innovators-a-shot-at-1m-seed-investment/2482779/daily0.7https://crstodayeurope.com/news/alon-harris-named-2025-recipient-of-robert-ritch-award-for-innovation-and-excellence-in-glaucoma/2482778/daily0.7https://crstodayeurope.com/news/topcon-healthcare-acquires-retinsight-to-accelerate-ai-powered-imaging-in-eye-care/2482777/daily0.7https://crstodayeurope.com/news/may-is-the-second-annual-inherited-retinal-disease-and-genetic-testing-month-at-prevent-blindness/2483760/daily0.7https://crstodayeurope.com/news/4dmt-announces-rmat-designation-granted-by-fda-for-4d-150-for-dme/2482776/daily0.7https://crstodayeurope.com/news/astellas-to-present-new-data-in-geographic-atrophy-at-upcoming-ophthalmology-annual-congresses/2482775/daily0.7https://crstodayeurope.com/news/oculis-to-present-its-innovative-late-stage-pipeline-candidates-at-upcoming-ophthalmology-conferences/2482774/daily0.7https://crstodayeurope.com/news/retinai-and-fvs-announce-ce-mdr-certification-for-co-developed-ai-based-dr-screening-algorithm-luxia/2482773/daily0.7https://crstodayeurope.com/news/zeiss-unveils-ai-powered-research-data-platform-collaboration-with-boehringer-ingelheim/2483759/daily0.7https://crstodayeurope.com/news/spyglass-pharma-presents-18-month-data-demonstrating-improvements-in-visual-acuity-with-iol-mounted-drug-delivery-platform/2482772/daily0.7https://crstodayeurope.com/news/heidelberg-engineering-showcases-technologies-to-enhance-the-future-of-imaging-technology-at-arvo/2482771/daily0.7https://crstodayeurope.com/news/datosx-and-topcon-healthcare-forge-strategic-partnership-to-accelerate-digital-health-innovation/2482770/daily0.7https://crstodayeurope.com/news/nanoscope-to-present-new-data-for-optogenetic-therapy-for-rp-at-eyecelerator-and-arvo/2482769/daily0.7https://crstodayeurope.com/news/fda-expands-luminopias-label-to-include-patients-8-to-12-with-amblyopia/2482768/daily0.7https://crstodayeurope.com/news/ace-vision-group-closes-294-million-series-b-financing-round/2482767/daily0.7https://crstodayeurope.com/news/azalea-vision-raises-eur9-million-to-further-develop-intelligent-connected-vision-platform/2482765/daily0.7https://crstodayeurope.com/news/topcon-healthcare-appoints-daniela-ferrara-md-phd-as-chief-medical-officer/2482764/daily0.7https://crstodayeurope.com/news/alcon-launches-unity-vcs-and-unity-cs-for-for-vitreoretinal-and-cataract-surgery/2482763/daily0.7https://crstodayeurope.com/news/medical-journals-cite-harassment-after-increased-scrutiny-from-justice-department/2482762/daily0.7https://crstodayeurope.com/news/university-of-cincinnati-study-finds-fear-of-vision-loss-is-a-barrier-to-cataract-surgery/2482761/daily0.7https://crstodayeurope.com/news/istar-medical-announces-positive-5-year-results-of-miniject-in-glaucoma-patients/2482760/daily0.7https://crstodayeurope.com/news/nordic-pharma-launches-authorized-generic-of-maxitrol/2482759/daily0.7https://crstodayeurope.com/news/focus-vitamins-launches-new-daily-eye-health-supplement-focus-lutein/2482758/daily0.7https://crstodayeurope.com/news/aurion-makes-leadership-announcements/2482757/daily0.7https://crstodayeurope.com/news/nordic-pharma-presents-data-and-patient-experience-study-for-lacrifill-canalicular-gel-at-ascrs/2482756/daily0.7https://crstodayeurope.com/news/allotex-accelerates-into-commercial-phase-and-appoints-michael-mrochen-as-new-ceo/2482755/daily0.7https://crstodayeurope.com/news/csi-dry-eye-software-announces-ken-barbet-as-new-chief-executive-officer/2482754/daily0.7https://crstodayeurope.com/news/johnson-johnson-to-present-new-data-for-tecnis-odyssey-at-ascrs/2482753/daily0.7https://crstodayeurope.com/news/bausch-lomb-returning-envista-iols-to-market-following-voluntary-recall/2482752/daily0.7https://crstodayeurope.com/news/glaukos-to-present-multiple-scientific-abstracts-at-ascrs/2482751/daily0.7https://crstodayeurope.com/news/first-atropine-eye-drop-to-slow-myopia-progression-in-children-approved-in-india/2482750/daily0.7https://crstodayeurope.com/news/sight-sciences-to-debut-omni-edge-surgical-system-at-ascrs/2482748/daily0.7https://crstodayeurope.com/news/neurotech-appoints-beth-marsh-as-chief-commercial-officer/2482746/daily0.7https://crstodayeurope.com/news/alcon-showcases-five-innovations-across-multiple-specialty-areas-at-ascrs-2025/2482744/daily0.7https://crstodayeurope.com/news/bvi-medical-announces-fda-510k-clearance-of-the-leos-laser-endoscopy-ophthalmic-system/2482743/daily0.7https://crstodayeurope.com/news/zeiss-to-showcase-new-digital-technologies-at-ascrs/2482742/daily0.7https://crstodayeurope.com/news/microsurgical-technology-mst-enters-strategic-partnership-with-mani-to-distribute-ophthalmic-surgical-blade-portfolio-in-the-us/2482739/daily0.7https://crstodayeurope.com/news/prevent-blindness-says-west-virginia-state-house-bill-would-imperil-childrens-vision/2482738/daily0.7https://crstodayeurope.com/news/andrew-chang-joins-bvi-medical-as-chief-commercial-officer/2482735/daily0.7https://crstodayeurope.com/news/eye-foundation-of-america-hosts-fundraising-gala/2482734/daily0.7https://crstodayeurope.com/news/tenpoint-therapeutics-submits-nda-to-fda-for-brimochol-pf-for-the-treatment-of-presbyopia/2482730/daily0.7https://crstodayeurope.com/news/nordic-pharma-receieves-ce-mark-approval-for-lacrifill-canalicular-gel/2482729/daily0.7https://crstodayeurope.com/news/orasis-launches-presbyopia-eyedrop-qlosi-in-the-us/2482728/daily0.7https://crstodayeurope.com/news/fda-once-again-rejects-aldeyras-nda-of-reproxalap-for-dry-eye-disease/2482727/daily0.7https://crstodayeurope.com/news/alcon-launches-clareon-panoptix-pro-trifocal-iol/2482725/daily0.7https://crstodayeurope.com/news/hoya-launches-visupro-advanced-focus-spectacle-lenses-for-patients-experiencing-first-symptoms-of-presbyopia/2482724/daily0.7https://crstodayeurope.com/news/rayner-expands-iol-manufacturing-capacity-to-meet-growing-demand/2482723/daily0.7https://crstodayeurope.com/news/sydnexis-announces-positive-chmp-opinion-in-europe-for-myopia-drug-candidate-syd-101/2482722/daily0.7https://crstodayeurope.com/news/maura-sweeney-appointed-chief-operating-officer-at-lighthouse-guild-1/2482720/daily0.7https://crstodayeurope.com/news/pantheon-vision-announces-partnership-with-eyedeal-medical-to-develop-bioengineered-corneal-implant/2482719/daily0.7https://crstodayeurope.com/news/alcon-acquires-majority-interest-in-aurion-biotech-to-advance-cell-therapy-for-corneal-endothelial-disease/2482718/daily0.7https://crstodayeurope.com/news/bausch-lomb-announces-voluntary-recall-of-envista-iols/2482717/daily0.7https://crstodayeurope.com/news/surrozen-discontinues-liver-program-shifts-focus-to-ophthalmology/2482716/daily0.7https://crstodayeurope.com/news/bausch-lomb-publishes-phase-4-data-on-the-early-effects-of-miebo-for-dry-eye-disease/2482715/daily0.7https://crstodayeurope.com/news/alcon-boosts-femtosecond-laser-technology-with-acquisition-of-lensar/2482713/daily0.7https://crstodayeurope.com/news/opus-genetics-presents-phentolamine-ophthalmic-solution-075-improves-visual-acuity-in-patients-with-dim-light-disturbances-world-cornea-congress-ix/2482711/daily0.7https://crstodayeurope.com/news/study-glaucoma-monitoring-lags-in-low-income-and-rural-areas/2482710/daily0.7https://crstodayeurope.com/news/nicox-announces-data-collection-complete-ncx-470-phase-3b-whistler-glaucoma-trial/2482709/daily0.7https://crstodayeurope.com/news/prevent-blindness-announces-matt-macdonald-as-chair-elect-of-board-of-directors/2482708/daily0.7https://crstodayeurope.com/news/iantrek-announces-positive-efficacy-and-safety-profile-of-its-bio-interventional-technology-to-enhance-uveoscleral-outflow-in-glaucoma-patients/2482707/daily0.7https://crstodayeurope.com/news/lighthouse-guild-appoints-thomas-panek-as-new-president-and-ceo/2482706/daily0.7https://crstodayeurope.com/news/staar-surgical-announces-restructure-of-leadership/2482705/daily0.7https://crstodayeurope.com/news/iluvien-earns-fda-approval-for-expansion-to-treat-chronic-posterior-uveitis/2482704/daily0.7https://crstodayeurope.com/news/harrow-launches-vevye-access-for-all-reducing-patient-barriers-for-dry-eye-disease-treatment/2482703/daily0.7https://crstodayeurope.com/news/bausch-lomb-announces-arisetm-orthokeratology-lens-system-in-the-united-states/2482702/daily0.7https://crstodayeurope.com/news/chinas-first-igf-1r-monoclonal-antibody-approved-innovent-biologics-announces/2482701/daily0.7https://crstodayeurope.com/news/experimental-stem-cell-treatment-shows-success-in-restoring-corneas/2482700/daily0.7https://crstodayeurope.com/news/60-of-glaucoma-patients-unaware-of-preservative-free-treatment-options-study-from-preservative-freedom-coalition/2482698/daily0.7https://crstodayeurope.com/news/sydnexis-announces-fda-acceptance-of-nda-for-syd-101-for-the-treatment-of-progression-of-pediatric-myopia/2482697/daily0.7https://crstodayeurope.com/news/harrow-secures-5-year-strategic-agreement-for-triesence-and-announces-next-generation-development/2482696/daily0.7https://crstodayeurope.com/news/radiusxr-and-glaukos-announce-a-new-collaboration-with-topcon-for-the-launch-of-inspire-visual-field-solution/2482695/daily0.7https://crstodayeurope.com/news/bvi-medical-raises-1-billion-to-fuel-global-growth/2482692/daily0.7https://crstodayeurope.com/news/lumata-health-secures-23-million-series-b-funding/2482691/daily0.7https://crstodayeurope.com/news/fda-approves-neurotechs-encelto-as-first-and-only-fda-approved-treatment-for-mactel/2482690/daily0.7https://crstodayeurope.com/news/haag-streit-launches-metis-900-new-ophthalmic-surgical-microscope/2482687/daily0.7https://crstodayeurope.com/news/adverum-biotechnologies-initiates-artemis-phase-3-study-to-evaluate-ixo-vec-for-wet-amd/2482686/daily0.7https://crstodayeurope.com/news/states-loosen-restrictions-for-international-medical-graduates-to-address-physician-shortages/2483758/daily0.7https://crstodayeurope.com/news/opthea-publishes-promising-phase-2b-trial-data-for-wet-amd/2482685/daily0.7https://crstodayeurope.com/news/nicox-announces-new-data-from-the-ncx-470-mont-blanc-trial-provides-development-updates/2482684/daily0.7https://crstodayeurope.com/news/altris-ai-launches-advanced-optic-disc-analysis-for-glaucoma-complementing-gcc-asymmetry-analysis/2482683/daily0.7https://crstodayeurope.com/news/forsight-robotics-achieves-iso-134852016-certification/2483757/daily0.7https://crstodayeurope.com/news/staar-surgical-announces-leadership-changes/2482682/daily0.7https://crstodayeurope.com/news/opus-genetics-announces-fda-fast-track-and-enrollment-updates-for-phentolamine-ophthalmic-solution/2482681/daily0.7